Manufacturer
Immedica Pharma
- Products listed
- 3
- Molecules
- 2
- Therapy areas
- 2
Immedica Pharma is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Immedica Pharma AB, Immedica Pharma US Inc, Immedica Pharma US Inc.
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Immedica Pharma products through licensed channels, with the documents your regulator needs.
Rare diseases and enzyme replacement
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Loargys 2 mg/0.4 mL injectionIntravenous, subcutaneous Cold chain | Pegzilarginase | US FDA | Available on request |
| Loargys 5 mg/mL injectionIntravenous, subcutaneous Cold chain | Pegzilarginase | US FDA | Available on request |
Neurology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ztalmy 50 mg/mL oral suspensionOral | Ganaxolone | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Immedica Pharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.